P38 mitogen activated protein kinase controls two successive-steps during the early mesodermal commitment of embryonic stem cells

Stem Cells and Development

Volumn 20, Issue 7, 2011, Pages 1233-1246

  Barruet, Emilie ^a   Hadadeh, Ola ^a   Peiretti, Franck ^a   Renault, Valérie M ^a   Hadjal, Yasmine ^a   Bernot, Denis ^a   Tournaire, Roselyne ^a   Negre, Didier ^a,b,c   Juhan Vague, Irène ^a   Alessi, Marie Christine ^a   Binétruy, Bernard ^a,d  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ DE LYON   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GENE INACTIVATION; HEART MUSCLE; MESODERM; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; SMOOTH MUSCLE; WILD TYPE;

EID: 79959848109     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0213     Document Type: Article

References (48)

1. Kashyap V, N Rezende, K Scotland, S Shaffer, J Persson, L Gudas and N Mongan. (2009). Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cell Dev 18:1093-1108.
2. Wobus AM. (2001). Potential of embryonic stem cells. Mol Aspects Med 22:149-164. (Pubitemid 32674347)
3. Wobus AM and KR Boheler. (2005). Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85:635-678. (Pubitemid 40404638)
4. Rohwedel J, K Guan and AM Wobus. (1999). Induction of cellular differentiation by retinoic acid in vitro. Cells Tissues Organs 165:190-202.
5. Ying Q-L, M Stavridis, D Griffiths, M Li and A Smith. (2003). Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. 21:183-186.
6. Dani C, AG Smith, S Dessolin, P Leroy, L Staccini, P Villageois, C Darimont and G Ailhaud. (1997). Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci 110: 1279-1285. (Pubitemid 27273698)
7. Hescheler J, BK Fleischmann, M Wartenberg, W Bloch, E Kolossov, G Ji, K Addicks and H Sauer. (1999). Establishment of ionic channels and signalling cascades in the embryonic stem cell-derived primitive endoderm and cardiovascular system. Cells Tissues Organs 165:153-164.
8. Pearson G, F Robinson, T Beers Gibson, BE Xu, M Karandikar, K Berman and MH Cobb. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183. (Pubitemid 32458157)
9. Cuenda A and S Rousseau. (2007). p38 MAP-Kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta-Mol Cell Res 1773:1358-1375. (Pubitemid 47125981)
10. Morooka T and E Nishida. (1998). Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J Biol Chem 273:24285-24288. (Pubitemid 28454911)
11. Rousseau S, F Houle, J Landry and J Huot. (1997). p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15:2169-2177. (Pubitemid 27493906)
12. Cuenda A and P Cohen. (1999). Stress-activated protein kinase-2=p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem 274:4341-4346.
13. Tamura K, T Sudo, U Senftleben, AM Dadak, R Johnson and M Karin. (2000). Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102:221-231.
14. Adams RH, A Porras, G Alonso, M Jones, K Vintersten, S Panelli, A Valladares, L Perez, R Klein and AR Nebreda. (2000). Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 6:109-116.
15. Allen M, L Svensson, M Roach, J Hambor, J McNeish and CA Gabel. (2000). Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med 191:859-870.
16. Aouadi M, F Bost, L Caron, K Laurent, Y Le Marchand Brustel and B Binetruy. (2006). p38 Mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem Cells 24:1399-1406. (Pubitemid 44464708)
17. Bost F, L Caron, I Marchetti, C Dani, Y Le Marchand-Brustel and B Binetruy. (2002). Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem J 361:621-627. (Pubitemid 34177831)
18. Kim JM, JM White, AS Shaw and BP Sleckman. (2005). MAPK p38{alpha} is dispensable for lymphocyte development and proliferation. J Immunol 174:1239-1244.
19. Caron L, F Bost, M Prot, P Hofman and B Binetruy. (2005). A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells. Oncogene 24:6281-6291. (Pubitemid 43080051)
20. Caron L, M Prot, M Rouleau, M Rolando, F Bost and B Binetruy. (2005). The Lac repressor provides a reversible gene expression system in undifferentiated and differentiated embryonic stem cell. Cell Mol Life Sci 62:1605-1612. (Pubitemid 41021582)
21. Dreux M, T Dao, J Fresquet, M Guerin, Z Julia, G Verney, D Durantel, F Zoulim, D Lavillette, F Cosset and B Bartosch. (2009). Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains. PLoS Pathog 5:e1000310.
22. Nègre D, P Mangeot, G Duisit, S Blanchard, P Vidalain, P Leissner, A Winter, C Rabourdin-Combe, M Mehtali, P Moullier, J Darlix and Cosset FL. (2000). Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther 7:1613-1623.
23. Murry CE and G Keller. (2008). Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132:661-680. (Pubitemid 351260059)
24. Gimond C, S Marchetti and G Pages. (2006). Differentiation of mouse embryonic stem cells into endothelial cells: genetic selection and potential use in vivo.MethodsMol Biol 330:303-329.
25. Li Z, Z Wang, Y Zheng, B Xu, R Yang, D Scadden and Z Han. (2005). Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1=CD31) during embryonic stem cell differentiation. J Cell Biochem 95:559-570. (Pubitemid 41420185)
26. Guo Y, J Ye and F Huang. (2007). p38alpha MAP kinasedeficient mouse embryonic stem cells can differentiate to endothelial cells, smooth muscle cells, and neurons. Dev Dyn 236:3383-3392. (Pubitemid 350276394)
27. Yamashita J, H Itoh, M Hirashima, M Ogawa, S Nishikawa, T Yurugi, M Naito, K Nakao and S-I Nishikawa. (2000). Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
28. Sone M, H Itoh, J Yamashita, T Yurugi-Kobayashi, Y Suzuki, Y Kondo, A Nonoguchi, N Sawada, K Yamahara, K Miyashita, K Park, M Shibuya, S Nito, S-I Nishikawa and K Nakao. (2003). Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation 107:2085-2088. (Pubitemid 36532188)
29. Alexopoulou A, J Couchman and J Whiteford. (2008). The CMV early enhancer=chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol 9:2.
30. Showell C, O Binder and F Conlon. (2004). T-box genes in early embryogenesis. Dev Dyn 229:201-218. (Pubitemid 38036834)
31. Fehling H Jr, G Lacaud, A Kubo, M Kennedy, S Robertson, G Keller and V Kouskoff. (2003). Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 130:4217-4227. (Pubitemid 37063436)
32. Duval D, M Malaise, B Reinhardt, C Kedinger and H Boeuf. (2004). A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. Cell Death Differ 11:331-341. (Pubitemid 38313142)
33. Zheng M, C Reynolds, S-H Jo, R Wersto, Q Han and R-P Xiao. (2004). Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury 10.1096=fj.04-2607fje. FASEB J:04-2607fje.
34. Davidson SM and M Morange. (2000). Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes. Dev Biol 218:146-160. (Pubitemid 30101965)
35. Eriksson M and S Leppa. (2002). Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of p19 embryonal carcinoma cells 10.1074=jbc.M107340200. J Biol Chem 277:15992-16001. (Pubitemid 34967882)
36. Graichen R, X Xu, SR Braam, T Balakrishnan, S Norfiza, S Sieh, SY Soo, SC Tham, C Mummery, A Colman, R Zweigerdt and BP Davidson. (2008). Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76:357-370. (Pubitemid 351522761)
37. Schmidt-Lucke C, L Rossig, S Fichtlscherer, M Vasa, M Britten, U Kamper, S Dimmeler and AM Zeiher. (2005). Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111:2981-2987. (Pubitemid 40814192)
38. Seeger FH, J Haendeler, DH Walter, U Rochwalsky, J Reinhold, C Urbich, L Rossig, A Corbaz, Y Chvatchko, AM Zeiher and S Dimmeler. (2005). p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111:1184-1191. (Pubitemid 40365481)
39. Keller G. (2005). Embryonic stemcell differentiation: emergence of a new era in biology andmedicine. Genes Dev 19:1129-1155. (Pubitemid 40696181)
40. Garry DJ and EN Olson. (2006). A common progenitor at the heart of development. Cell 127:1101-1104. (Pubitemid 44894531)
41. Lluis F, E Perdiguero, AR Nebreda and P Munoz-Canoves. (2006). Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol 16:36-44. (Pubitemid 43077093)
42. de Angelis L, J Zhao, JJ Andreucci, EN Olson, G Cossu and JC McDermott. (2005). Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway. Dev Biol 283:171-179. (Pubitemid 40828849)
43. Jones NC, KJ Tyner, L Nibarger, HM Stanley, DDW Cornelison, YV Fedorov and BB Olwin. (2005). The p38{alpha}= {beta} MAPK functions as a molecular switch to activate the quiescent satellite cell 10.1083=jcb.200408066. J Cell Biol 169: 105-116. (Pubitemid 40562918)
44. Jones NC, YV Fedorov, RS Rosenthal and BB Olwin. (2001). ERK1=2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol 186:104-115.
45. Wu Z, PJ Woodring, KS Bhakta, K Tamura, F Wen, JR Feramisco, M Karin, JYJ Wang and PL Puri. (2000). p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 20:3951-3964. (Pubitemid 30314494)
46. Perdiguero E, V Ruiz-Bonilla, L Gresh, L Hui, E Ballestar, P Sousa-Victor, B Baeza-Raja, M Jardi, A Bosch-Comas, M Esteller, C Caelles, AL Serrano, EF Wagner and P Munoz- Canoves. (2007). Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38[alpha] in abrogating myoblast proliferation. EMBO J 26:1245-1256. (Pubitemid 46398710)
47. Kunath T, MK Saba-El-Leil, M Almousailleakh, J Wray, S Meloche and A Smith. (2007). FGF stimulation of the Erk1=2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134:2895-2902. (Pubitemid 47386902)
48. Amura CR, L Marek, RA Winn and LE Heasley. (2005). Inhibited neurogenesis in JNK1-deficient embryonic stem cells. Mol Cell Biol 25:10791-10802. (Pubitemid 41747124)